Clinical Nutrition for Diabetes Care Market Size, Share & Trends Analysis Report By Product (Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas), By Stage (Adult, Pediatric), By Sales Channel (Online, Retail, Institutional Sales) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Clinical Nutrition for Diabetes Care Market Size

The global clinical nutrition for diabetes care market size was valued at USD 4.33 billion in 2025 and is projected to grow from USD 4.56 billion in 2026 to USD 6.89 billion by 2034, registering a CAGR of 5.3% during the forecast period from 2026 to 2034. North America dominated the clinical nutrition for diabetes care market with a market share of 38.2% in 2025.

Clinical nutrition for diabetes care refers to specialized dietary interventions and nutritional strategies designed to manage and improve the health outcomes of people with diabetes mellitus. It entails using evidence-based nutrition treatment to help diabetic patients maintain blood sugar control, avoid complications, and enhance their overall metabolic health.

In recent years, the market for clinical nutrition products and services aimed at diabetes management has expanded significantly. This expansion can be ascribed to several factors, including rising diabetes prevalence worldwide, increased knowledge of the importance of nutrition in diabetes management, advances in nutritional research and technology, and a greater emphasis on preventive healthcare.

Furthermore, the trend toward customized treatment and the use of novel approaches, such as digital health solutions and telemedicine, have propelled the growth of the clinical nutrition market for diabetes care. With the continuous emphasis on holistic methods of managing chronic diseases such as diabetes, the market for clinical nutrition solutions will grow further in the coming years.

Product Insights

Oral clinical nutrition for diabetes care led the market, accounting for 70%. Oral nutrition products include various nutritional supplements, specialty foods, and meal replacements intended to be ingested orally as part of a person's regular diet. These products are often available in various formats, including powders, shakes, bars, and ready-to-drink beverages. Individuals with diabetes who can maintain enough oral intake benefit greatly from oral nutrition, providing essential nutrients, vitamins, and minerals. These items are practical, easy to use, and may be incorporated into daily meal plans to help people with diabetes manage their blood sugar, weight, and general nutritional needs.

Enteral feeding formulae in diabetes care will increase during the projection period. The need for diabetes-specific enteral feeding formulae is rising, owing to several studies demonstrating their efficacy in managing diabetic patients who require enteral nourishment. DSFs outperformed standard formulae regulating HbA1c and insulin responsiveness in diabetic individuals on enteral feed. As a result, using diabetes-specific enteral feeding formulae provides advantages regarding blood sugar control and comprehensive treatment for diabetes patients who require enteral nourishment.

Request Customizationto receive a tailored report.

Stage Insights

Adults dominated the diabetic clinical nutrition market in 2023, with a share of more than 80%, owing to the rising prevalence of nutritional deficiencies and malnutrition among adults. The adult segment of the clinical nutrition for diabetes care market includes products and services designed to fulfill the dietary demands of adults with diabetes. This market encompasses various oral nutrition products, enteral feeding formulae, and parenteral nutrition solutions to improve blood sugar control, weight management, and overall nutritional adequacy in adult diabetes patients.

Additionally, adults are more likely to have diminished muscle strength, vitamin and calcium deficiencies among women over the age of 30, apathy, lowered immunity, hypertension, and weariness. This causes nutritional insufficiency among the adult population. According to the OECD, India, Sri Lanka, Pakistan, and Bangladesh significantly contribute to the global burden. The adult group is also expected to increase quickly during the projection period. Globally, the number of persons with diabetes is increasing due to increased urbanization, sedentary lifestyles, and bad eating habits. Physical inactivity is common in adults and contributes to poor blood sugar control, weight gain, and insulin resistance. The growing geriatric population is also a crucial factor driving category growth.

Pediatric nutrition interventions seek to deliver age-appropriate nutrients, vitamins, and minerals required for healthy growth and development, encouraging optimal nutritional status and minimizing diabetes-related problems in children.

Sales Channels Insights

Institutional sales dominated the market, accounting for more than 45% of total revenue. Institutional sales refer to distributing clinical nutrition items for diabetic care to healthcare institutions such as hospitals, clinics, long-term care homes, and rehabilitation centers. This sales channel is for healthcare professionals and institutional caregivers who manage the dietary needs of diabetic patients in clinical settings. Institutional sales may include large purchases of oral nutrition supplements, enteral feeding formulas, and parenteral nutrition solutions for patient care and treatment regimens.

Moreover, the increased prevalence of diseases, combined with innovations in hospital care, increases patient hospital visits, driving the industry. Furthermore, as patient awareness grows, the inclination to receive diabetic care nutrition prescriptions through formal hospital channels has increased.

The online sales segment is expected to grow the fastest over the projected period. Online sales deliver clinical nutrition items for diabetes management via e-commerce platforms, company websites, and online marketplaces. Consumers looking for therapeutic nutrition solutions for diabetes treatment will find this sales channel convenient, accessible, and with a diverse product offering. Patients and caregivers can explore, purchase, and receive products such as oral nutrition supplements, enteral feeding formulas, and specific dietary foods from the convenience of their homes, with the option of home delivery.

Telemedicine and pharmacy advancements have made it easier to distribute clinical nutrition products globally, allowing manufacturers to reach out to underrepresented areas. As a result, online sales are increasing as customer demand for diabetes care supplements rises through online platforms and businesses.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global clinical nutrition for diabetes care market shareholder and is estimated to grow at a CAGR of 5.5% over the forecast period. In 2023, North America held 35% of the clinical nutrition for the diabetes treatment market. A solid healthcare infrastructure, advantageous reimbursement regulations, and the existence of prominent clinical nutrition companies all contribute to the region's significant market share. Furthermore, solid governmental and private investment in healthcare and shifting toward more holistic treatment regimens have benefited the region's market growth.

Additionally, according to Diabetes Canada's February 2023 prebudget proposal, roughly 2.4 million people in Ontario, or 30% of the population, will have diabetes or prediabetes in 2023. According to the proposal, diabetes prevalence in Ontario is predicted to climb by 25% over the next decade. Such disorders necessitate long-term therapeutic nutritional support; diseases like diabetes are likely to drive market expansion during the forecast period.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Clinical Nutrition for Diabetes Care Market Trends

Europe is anticipated to exhibit a CAGR of 5.9% over the forecast period. The clinical nutrition for diabetes treatment market in Europe was the second-largest regional market in 2023. The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD) recommends consuming plant-based, minimally processed foods to manage diabetes, citing scientific data. Individuals with diabetes in Europe can effectively manage their illness, prevent complications, and enhance their overall quality of life by adhering to evidence-based dietary recommendations and obtaining personalized medical nutrition therapy (MNT).

In addition, England's type 2 diabetes patients are excused from paying for their drugs, which encourages adherence to their approved treatment plans due to the availability of free prescriptions. Positive government actions would help to promote the country's market growth.

Asia-Pacific holds a significant market share. The clinical nutrition for diabetes treatment market in Asia-Pacific will increase over the next several years. According to PubMed, the increasing incidence of diabetes in the Asia-Pacific area is a significant concern, with more than 60% of diabetics living in Asia, particularly in China and India. With the increased prevalence of diabetes in the Asia-Pacific area, there is a growing realization of the significance of implementing effective measures to address these difficulties, including optimal dietary management for diabetics. Baxter International Inc., a global clinical nutrition company, has spearheaded programs in India to improve awareness about the correct diabetes diet. Furthermore, in August 2022, Bayer introduced a tablet to treat chronic kidney disease associated with type 2 diabetes.

List of Key and Emerging Players in Clinical Nutrition for Diabetes Care Market